Other news

RTM receives marketing authorisation for Fludeoxyglucose (18F)
We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018....

18F-FDOPA now available
Fluorodopa (18F) is now available for clinical studies and - with doctor's certificate - for routine...

GMP-certificate received
Today we received our GMP-certificate!The results of the inspection were excellent and no shortcomin...

1st production QuiremSpheres
On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the s...
Interested in a collaboration?
Contact us to discuss the possibilities.